Clinical Research Directory
Browse clinical research sites, groups, and studies.
Serum IGF-1 and IGF-1Ec in Malignancy Assessment
Sponsor: Çanakkale Onsekiz Mart University
Summary
This cross-sectional study investigates the relationship between serum IGF-1 and IGF-1Ec (E-peptide/MGF) levels and tumor burden in patients with solid tumors. By analyzing serum samples using ELISA and correlating them with clinical data such as tumor stage, size, metastasis, and lymph node involvement, the study aims to explore whether these biomarkers-particularly IGF-1Ec and the IGF-1Ec/IGF-1 ratio-can reflect tumor progression and serve as potential prognostic indicators.
Official title: Evaluation of Serum IGF-1 and IGF-1Ec (E-peptide/MGF) Levels and Their Association With Tumor Burden in Patients With Solid Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-04-01
Completion Date
2026-12
Last Updated
2025-09-03
Healthy Volunteers
No
Locations (1)
Çanakkale Onsekiz Mart University
Çanakkale, Turkey (Türkiye)